Hone Health Raises $228M, but Only $28M Is Equity
Hone Health, a New York physician-led longevity telehealth company, announced $228M in financing on Wednesday. Read the structure before the headline: $28M is equity, a Series A extension led by MarcyPen Capital Partners, and $200M is growth financing from General Catalyst's Customer Value Fund, a non-dilutive vehicle that funds customer acquisition and gets repaid from the revenue those customers bring in. Press release: https://www.prnewswire.com/news-releases/hone-health-raises-228m-to-expand-physician-led-longevity-care-for-men-and-women-302943964.html
The equity side brought in Pentland Ventures, Kinship Ventures (co-founded by Gwyneth Paltrow and Moj Mahdara), Hanwha and Gannet Capital, plus a celebrity strategic group assembled by David Grutman that includes the Jonas Brothers and Kelly Rowland. Total equity raised is now $65M, after a $33M Series A in January 2025. No valuation was disclosed.
What Hone sells: biomarker testing, one-on-one physician consults and ongoing treatment, with testosterone replacement and menopause hormone therapy at the core, plus weight management, peptides, thyroid, heart and sexual health. The company says it has treated more than 200,000 patients, and that the data runs through an in-house AI clinical platform it calls Longevity OS. The money goes to new clinical pathways and that AI layer, and alongside the round it launched Hone Black, a concierge tier with 1,600+ markers and a dedicated physician team.
The $200M is the interesting part. Customer Value Fund money only works for businesses whose cost to acquire a subscriber and payback period are predictable enough to underwrite like a loan. That General Catalyst wrote that check says more about Hone's unit economics than the $28M does about its valuation.
← Back to all articles
The equity side brought in Pentland Ventures, Kinship Ventures (co-founded by Gwyneth Paltrow and Moj Mahdara), Hanwha and Gannet Capital, plus a celebrity strategic group assembled by David Grutman that includes the Jonas Brothers and Kelly Rowland. Total equity raised is now $65M, after a $33M Series A in January 2025. No valuation was disclosed.
What Hone sells: biomarker testing, one-on-one physician consults and ongoing treatment, with testosterone replacement and menopause hormone therapy at the core, plus weight management, peptides, thyroid, heart and sexual health. The company says it has treated more than 200,000 patients, and that the data runs through an in-house AI clinical platform it calls Longevity OS. The money goes to new clinical pathways and that AI layer, and alongside the round it launched Hone Black, a concierge tier with 1,600+ markers and a dedicated physician team.
The $200M is the interesting part. Customer Value Fund money only works for businesses whose cost to acquire a subscriber and payback period are predictable enough to underwrite like a loan. That General Catalyst wrote that check says more about Hone's unit economics than the $28M does about its valuation.
Comments